Complete regression of established spontaneous mammary carcinoma and the therapeutic prevention of genetically programmed neoplastic transition by IL-12/pulse IL-2: induction of local T cell infiltration, Fas/Fas ligand gene expression, and mammary epithelial apoptosis.

MLA

Wigginton, J. M., et al. “Complete Regression of Established Spontaneous Mammary Carcinoma and the Therapeutic Prevention of Genetically Programmed Neoplastic Transition by IL-12/Pulse IL-2: Induction of Local T Cell Infiltration, Fas/Fas Ligand Gene Expression, and Mammary Epithelial Apoptosis.” Journal of Immunology (Baltimore, Md. : 1950), vol. 166, no. 2, Jan. 2001, pp. 1156–68. EBSCOhost, https://doi.org/10.4049/jimmunol.166.2.1156.

APA

Wigginton, J. M., Park, J. W., Gruys, M. E., Young, H. A., Jorcyk, C. L., Back, T. C., Brunda, M. J., Strieter, R. M., Ward, J., Green, J. E., & Wiltrout, R. H. (2001). Complete regression of established spontaneous mammary carcinoma and the therapeutic prevention of genetically programmed neoplastic transition by IL-12/pulse IL-2: induction of local T cell infiltration, Fas/Fas ligand gene expression, and mammary epithelial apoptosis. Journal of Immunology (Baltimore, Md. : 1950), 166(2), 1156–1168. https://doi.org/10.4049/jimmunol.166.2.1156

Chicago

Wigginton, J M, J W Park, M E Gruys, H A Young, C L Jorcyk, T C Back, M J Brunda, et al. 2001. “Complete Regression of Established Spontaneous Mammary Carcinoma and the Therapeutic Prevention of Genetically Programmed Neoplastic Transition by IL-12/Pulse IL-2: Induction of Local T Cell Infiltration, Fas/Fas Ligand Gene Expression, and Mammary Epithelial Apoptosis.” Journal of Immunology (Baltimore, Md. : 1950) 166 (2): 1156–68. doi:10.4049/jimmunol.166.2.1156.